CytoAgents

Pittsburgh, PA · Founded 2018 · Privately Held (backing)

Developer of pharmaceutical drugs designed to treat cytokine release syndrome. CytoAgents is based in Pittsburgh, PA and was founded in 2018. It was valued at $52 million at its later-stage round in May 2023, the last priced event on record. It has raised $38.6 million across 2 recorded rounds; the latest was a $7 million early-stage round in May 2023.

PMV mark · valuation
$52.0M
Oct 2026
Priced at
its later-stage round
May 2023
Total raised
$38.6M
Last round
Early Stage VC
May 2023
How much has CytoAgents raised?
$38.6Macross 2 recorded rounds · Jul 2021 – May 2023

Most recently, CytoAgents raised $7.0M in its Early Stage VC (May 2023).

Free account
More of CytoAgents with a free account
  • ·The complete investor list: 15 names
  • ·Watch CytoAgents: the Monday email on marks, rounds and moves
Create free account
No card required

Membership and data by Private Market View

CytoAgents round by round

2 rounds
May 2023Early Stage VC$7.0MSEC filing▮
23 investors participated
Jul 2021Early Stage VC$6.1MSEC filing▮
23 investors participated

How much has CytoAgents raised?

CytoAgents has raised $38.6 million in total; 2 of its rounds are on record. The largest on record was a $7 million early-stage round in May 2023.

CytoAgents has filed 2 Form Ds with the SEC since 2021, most recently in May 2023 ($7 million sold to 23 investors).

CytoAgents investors

15 investors are on record for CytoAgents, including National Institutes of Health, Innovation Works, Richard King Mellon Foundation and AlphaLab Health. The early-stage round in May 2023 drew 23 investors.

For fundraisers
Raising for a company like CytoAgents?

15 investors have backed CytoAgents.

See all 15 investors →

Frequently asked about CytoAgents

How much has CytoAgents raised?
CytoAgents has raised $38.6M in total across 2 recorded funding rounds.
When was CytoAgents's last funding round?
CytoAgents's most recent recorded round was Early Stage VC in May 2023, raising $7.0M.